ArticleEndocrine connections2025
Phase 1 clinical trial of eneboparatide, a novel PTH receptor 1 agonist.
Michel Ovize et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this paperpooled itcites it
ArticleEndocrine connections2025
Michel Ovize et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.